Zacks Research upgraded shares of Glanbia (OTCMKTS:GLAPY – Free Report) to a hold rating in a report published on Tuesday morning,Zacks.com reports.
Glanbia Price Performance
OTCMKTS:GLAPY opened at $98.24 on Tuesday. The firm’s fifty day moving average price is $92.97 and its two-hundred day moving average price is $86.33. Glanbia has a one year low of $52.40 and a one year high of $99.00. The company has a current ratio of 1.67, a quick ratio of 0.89 and a debt-to-equity ratio of 0.41.
Glanbia Company Profile
Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland. The company operates through two principal divisions: Performance Nutrition and Glanbia Nutritionals. Performance Nutrition develops and markets sports and lifestyle nutrition products, including powders, bars and ready-to-drink beverages for athletes and fitness enthusiasts. Glanbia Nutritionals supplies dairy-based ingredients, specialty cheeses, whey proteins, nutrient premixes and functional food solutions to food, beverage and supplement manufacturers worldwide.
Glanbia was formed in 1997 through the merger of Avonmore Food plc and Waterford Foods plc.
Featured Articles
- Five stocks we like better than Glanbia
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
